Quick Answer
Jade Biosciences, Inc. reported Shares Outstanding of 49.32 million shares for fiscal year 2025.
Jade Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 49.32M | +1242.7% |
| 2024 | 3.67M | -86.8% |
| 2023 | 27.76M | +12.3% |
| 2022 | 24.72M | +1.3% |
| 2021 | 24.41M | +9942.3% |
| 2020 | 243,076 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 32.63M | +13.0% | +0.0% |
| June 30, 2025 | 32.63M | +13.1% | +12.6% |
| March 31, 2025 | 28.99M | +3.9% | +689.2% |
| December 31, 2024 | 3.67M | -86.8% | -87.3% |
| September 30, 2024 | 28.87M | +4.4% | +0.0% |
| June 30, 2024 | 28.85M | +4.5% | +3.4% |
| March 31, 2024 | 27.90M | +12.4% | +0.5% |
| December 31, 2023 | 27.76M | +12.3% | +0.4% |
- Jade Biosciences, Inc. showed an increase of +1242.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2020–2025 period, Jade Biosciences, Inc.’s shares outstanding has grown by 20188.4% (from 243.1 thousand shares to 49.32 million shares).
- The most recent figure is from Jade Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: